NEXT Bio-Research Services LLC. d/b/a NEXT Molecular Analytics Revenue and Competitors

Chester, VA USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • NEXT Bio-Research Services LLC. d/b/a NEXT Molecular Analytics's estimated annual revenue is currently $2.6M per year.(i)
  • NEXT Bio-Research Services LLC. d/b/a NEXT Molecular Analytics's estimated revenue per employee is $155,000

Employee Data

  • NEXT Bio-Research Services LLC. d/b/a NEXT Molecular Analytics has 17 Employees.(i)
  • NEXT Bio-Research Services LLC. d/b/a NEXT Molecular Analytics grew their employee count by -6% last year.

NEXT Bio-Research Services LLC. d/b/a NEXT Molecular Analytics's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.4M9-10%N/AN/A
#2
$4.3M284%N/AN/A
#3
$1.1M70%N/AN/A
#4
$3.5M45-52%$56.5MN/A
#5
$0.3M20%N/AN/A
#6
$4.5M2921%N/AN/A
#7
$1.9M129%N/AN/A
#8
$7M455%N/AN/A
#9
$6.7M435%N/AN/A
#10
$2M13-13%N/AN/A
Add Company

What Is NEXT Bio-Research Services LLC. d/b/a NEXT Molecular Analytics?

NEXT Bio-Research, Services continues a 23 year history in providing comprehensive integrated project support to investigators in the biotech and pharmaceutical sectors. We also provide medical testing services to physicians using state-of-the-art platforms. NEXT Bio-Research Services was founded by three long standing colleagues who have worked together these past 23 years and collectively represent more than 100 years’ experience in life science technologies. NEXT Bio-Research Services is focused in (1) clinical testing using molecular and biochemical techniques; (2) molecular genetics of pharmacogenomics and cancer; (3) contract research in drug discovery and development with private sector customers; and (4) laboratory support of human clinical trials. We function as an extension of your own laboratory in helping you to bring their products from discovery to market. Our laboratories are certified under the Clinical Laboratory Improvement Amendments (CLIA) act and our contract research services are offered individually or can be integrated to support product development from discovery to market with full regulatory support under FDA GLP Guidelines 21 CFR 58.

keywords:N/A

N/A

Total Funding

17

Number of Employees

$2.6M

Revenue (est)

-6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.8M176%N/A
#2
$3.5M1755%N/A
#3
$0.7M1820%N/A
#4
$0.7M1820%N/A
#5
$2.4M18N/AN/A